Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers

NCT05860530 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: The test olaparib tablet (T)
DRUG: The reference olaparib tablet (R)

Sponsor

Qilu Pharmaceutical Co., Ltd.